Outcome of treatment with a 10-week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014-2023)
- PMID: 39113405
- DOI: 10.1111/jsap.13772
Outcome of treatment with a 10-week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014-2023)
Abstract
Objectives: The aim of this retrospective clinical study was to evaluate and report response to treatment with a 10-week maintenance-free COP (COP-10) protocol in a cohort of 27 cats with intermediate or large cell lymphoma. Additionally, to identify any potential prognostic factors for predicting the treatment response.
Materials and methods: The medical records of cats diagnosed with intermediate or large cell lymphoma in a single institution in the period 2014 to 2023 and treated with COP-10 as first-line treatment were reviewed.
Results: Twenty-seven cats were included in the study. The median age was 10 years, 67% of the cats were in stages I to II and the most common anatomical location was alimentary (37%). The overall response rate was 65%, with 38% of cats achieving complete remission and 27% partial remission. For cats achieving complete remission, the median progression-free interval and the median lymphoma-specific survival time were both 1,139 days. For cats in partial remission, the median progression-free interval and the median lymphoma-specific survival time were 53 and 210 days, respectively. Clinical stage was significantly related to treatment response and survival time.
Clinical significance: Treatment with the short protocol COP-10 resulted in remission rates and durable first remissions for cats achieving complete remission comparable to responses seen with longer-duration chemotherapy protocols. The results from this study may impact economic and logistic decisions for owners, as well as the quality of life for patients in the future.
© 2024 The Author(s). Journal of Small Animal Practice published by John Wiley & Sons Ltd on behalf of British Small Animal Veterinary Association.
References
-
- Clark, T.G., Bradburn, M.J., Love, S.B. & Altman, D.G. (2003) Survival analysis part I: basic concepts and first analyses. British Journal of Cancer, 89, 232–238. Available from: https://doi.org/10.1038/sj.bjc.6601118
-
- Collette, S.A., Allstadt, S.D., Chon, E.M., Vernau, W., Smith, A.N., Garrett, L.D. et al. (2016) Treatment of feline intermediate‐ to high‐grade lymphoma with a modified university of Wisconsin–Madison protocol: 119 cases (2004–2012). Veterinary and Comparative Oncology, 14, 136–146. Available from: https://doi.org/10.1111/vco.12158
-
- Economu, L., Stell, A., O'Neill, D.G., Schofield, I., Stevens, K. & Brodbelt, D. (2021) Incidence and risk factors for feline lymphoma in UK primary‐care practice. Journal of Small Animal Practice, 62, 97–106. Available from: https://doi.org/10.1111/jsap.13266
-
- Egenvall, A., Nødtvedt, A., Häggström, J., Ström Holst, B., Möller, L. & Bonnett, B.N. (2009) Mortality of life‐insured Swedish cats during 1999–2006: age, breed, sex, and diagnosis. Journal of Veterinary Internal Medicine, 23, 1175–1183.
-
- Fabrizio, F., Calam, A.E., Dobson, J.M., Middleton, S.A., Murphy, S., Taylor, S.S. et al. (2014) Feline mediastinal lymphoma: a retrospective study of signalment, retroviral status, response to chemotherapy and prognostic indicators. Journal of Feline Medicine and Surgery, 16, 637–644. Available from: https://doi.org/10.1177/1098612X13516621
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
